BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
2.880
+0.010 (0.35%)
Apr 25, 2025, 4:00 PM EDT - Market closed
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $5.17 million as of April 25, 2025. Its market cap has decreased by -54.59% in one year.
Market Cap
5.17M
Enterprise Value
1.02M
1-Year Change
-54.59%
Ranking
Category
Stock Price
$2.88
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $5.17M, a decrease of -87.72%. That is a compound annual growth rate of -36.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 5.17M | 2.96% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | 236.28M | 460.98% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 212.59B |
| BHP Group | 123.58B |
| Rio Tinto Group | 104.19B |
| The Sherwin-Williams Company | 83.64B |
| Southern Copper | 76.30B |
| Ecolab | 67.98B |
| Newmont | 61.99B |
| CRH plc | 61.77B |